The waiting list has become the product: management describes demand accumulating faster than the company can absorb it,
The model's full reasoning — Q4 2022 call → NO我们根据提供的财报电话会议记录来判断。管理层是否传达出公司正在积累无法满足的需求队列?他们是否在管理队列而不是寻找需求? 从记录看,管理层主要讨论的是: - 增加RNS系统的利用率,通过扩大患者选择、管理患者管道、推动更多处方者和植入中心采用。 - 他们提到“管理患者管道”和“护士导航员”帮助引导患者,但这是关于教育患者和推动他们进入诊断过程,而不是说需求超过处理能力。 - 他们提到DIXI产品提供早期患者参与机会,但这是为了增加RNS患者管道,而不是说他们无法处理。 - 他们提到2023年收入预期增长,但增长来自初始植入和DIXI,而替换收入下降。没有提到积压订单或等待名单。 - 他们提到NAUTILUS研究正在招募患者,但这是临床试验,不是商业需求队列。 - 他们提到“增加利用率”和“扩大患者选择”,但这些都是为了吸引更多需求,而不是处理积压。 管理层没有说需求超过他们的处理能力。相反,他们强调需要教育医生和患者,推动更多采用。他们提到EMU患者量稳定,但未说无法处理。他们提到“管理患者管道”是主动寻找和引导患者,而不是应对积压。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| TT | Trane Technologies plc | Q3 2022 | 2022-11-02 | A |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| RMD | ResMed Inc. | Q4 2022 | 2022-08-11 | C |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| ZBRA | Zebra Technologies Corporation | Q2 2022 | 2022-08-02 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| WHF | WhiteHorse Finance, Inc. | Q1 2022 | 2022-05-10 | B+ |
| CLAR | Clarus Corporation | Q1 2022 | 2022-05-09 | B |
| CCK | Crown Holdings, Inc. | Q1 2022 | 2022-04-26 | C+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| HY | Hyster-Yale Materials Handling, Inc. | Q3 2021 | 2021-11-06 | D |
| HSY | The Hershey Company | Q3 2021 | 2021-10-28 | C |
| SLAB | Silicon Laboratories Inc. | Q3 2021 | 2021-10-27 | B |
| CROX | Crocs, Inc. | Q3 2021 | 2021-10-21 | B+ |
| CTSH | Cognizant Technology Solutions Corporati | Q2 2021 | 2021-07-28 | B |
| GLW | Corning Incorporated | Q2 2021 | 2021-07-27 | B+ |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| SAND | Sandstorm Gold Ltd. | Q1 2018 | 2018-08-02 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| BPMC | Blueprint Medicines Corporation | Q1 2018 | 2018-05-02 | C+ |
| MTSI | MACOM Technology Solutions Holdings, Inc | Q1 2018 | 2018-02-06 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| ENB | Enbridge Inc. | Q1 2016 | 2016-05-12 | B |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TT · Q3 2022 → YESThe question is: Does management convey that the company is currently ACCUMULATING A QUEUE OF DEMAND IT CANNOT YET SERVE, and that they're managing that queue rather than finding demand? YES The transcript shows management describing a backlog of $6.4 billion that is "unprecedented" and "at elevated levels well into 2023," with Americas commercial HVAC backlog "up more than 70% year-over-year and more than 200% of historical norms." They note bookings remain "extremely high" with book-to-bill over 100%, and they are "managing" the queue through extended lead times, sequencing applied jobs, and accelerating revenue recovery from disruptions. While supply chain tightness is mentioned as a constraint, the language centers on demand already arriving and stacking up faster than capacity allows, with management focusing on processing, prioritizing, and expanding throughput rather than primarily attracting new demand. This aligns with the criteria for YES. No, the answer is not NO, as the queue is not merely routine or one-time. The posture is that demand is pressing in, and they are actively managing it. So the answer is YES. (borderline due to emphasis on share gains and innovation, but backlog and lead times dominate the narrative) . The final answer is YES. I think it's clear from the transcript that they are managing the queue.
SLAB · Q3 2021 → YESThe question is: Does management convey that the company is currently accumulating a queue of demand it cannot yet serve, and spending energy managing that queue rather than finding demand? YES The transcript shows management describing a widening gap where demand is increasing faster than supply can be ramped up, with explicit references to demand continuing to arrive and outpace capacity ("demand is continuing to increase at a faster rate," "demand increase much faster than we're able to increment up supply," "those gaps continue to widen"). They are actively managing this by prioritizing supply increments, equitable pricing to preserve relationships, and expanding throughput through new capacity and protocols, rather than primarily seeking new demand. This aligns with the criteria for a queue of unserved demand already accumulating and pressing on the company's ability to absorb it. The constraint stems from their manufacturing capacity (wafer supply), but the directional pressure and management focus on absorbing/expanding that demand confirm the posture.
CLAR · Q1 2022 → YESThe question is: Does management convey that the company is currently ACCUMULATING A QUEUE OF DEMAND IT CANNOT YET SERVE, and that they're managing that queue rather than finding demand? YES Management repeatedly describes a backlog of committed demand (strong order books, $10M in-transit inventory, $270M inventory purchases aligned to bookings, strong bookings across segments) that supply-chain, logistics, and capacity constraints are preventing them from converting into revenue today. They explicitly frame their current effort as “hand 10 million in demand… stuck in transit,” “prioritizing ammo, OEM, green box,” “allocating inventory,” “increasing capacity,” and “being scrappy” to serve the queue that is already arriving faster than they can absorb it. While some constraints are on inputs they buy, the transcript centers on their own customers and orders waiting in line and on their active management of that queue rather than on attracting new demand. The posture is therefore affirmative under the stated criteria.